0001209191-22-022524.txt : 20220404 0001209191-22-022524.hdr.sgml : 20220404 20220404170854 ACCESSION NUMBER: 0001209191-22-022524 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220404 DATE AS OF CHANGE: 20220404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Combs Andrew CENTRAL INDEX KEY: 0001825005 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39527 FILM NUMBER: 22803602 MAIL ADDRESS: STREET 1: C/O PRELUDE THERAPEUTICS INCORPORATED STREET 2: 200 POWDER MILL ROAD CITY: WILMINGTON STATE: DE ZIP: 19803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Prelude Therapeutics Inc CENTRAL INDEX KEY: 0001678660 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811384762 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 POWDER MILL ROAD CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: (302) 547-3768 MAIL ADDRESS: STREET 1: 200 POWDER MILL ROAD CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER COMPANY: FORMER CONFORMED NAME: Prelude Therapeutics Inc. DATE OF NAME CHANGE: 20160630 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-31 0 0001678660 Prelude Therapeutics Inc PRLD 0001825005 Combs Andrew C/O PRELUDE THERAPEUTICS INCORPORATED 200 POWDER MILL ROAD WILMINGTON DE 19803 0 1 0 0 EVP, Head of Chemistry Common Stock 2022-03-31 4 M 0 36062 1.89 A 304442 D Employee Stock Option (right to buy) 1.89 2022-04-01 4 M 0 36062 0.00 D 2030-03-26 Common Stock 36062 50397 D Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met. The stock option vested as to 25% of the total shares on March 6, 2021, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. /s/ Laurent Chardonnet, as Attorney-in-Fact 2022-04-04